Key result
Obesity was associated with significantly lower serum omentin-1 levels compared to non-obese individuals (median 140.31 vs 210.97 ng/mL; p<0.001).
Why the study?
This study aimed to determine differences in omentin-1 levels between obese and non-obese individuals, and to evaluate correlations with BMI and waist circumference.
Are serum omentin-1 levels lower in obese individuals compared to non-obese individuals, and do they correlate with BMI and waist circumference?
Population
70 subjects (37 obese and 33 non-obese)
Comparison
Obese group vs non-obese group
Design
Cross-sectional study
Authors
Loading...
Lower omentin-1 in obesity is hypothesis-generating; cross-sectional data leave causal and clinical roles open.
Cross-Sectional (n=70)
Are serum omentin-1 levels lower in obese individuals compared to non-obese individuals, and do they correlate with BMI and waist circumference?
Absolute Event Rate: 140.31% vs 210.97%
p-value: p=< 0.001
Obesity is associated with significantly lower levels of the anti-inflammatory adipokine omentin-1, which negatively correlates with BMI and waist circumference.
Lestari et al. (2021) conducted a cross-sectional in Obesity (n=70). Obesity vs. Non-obese was evaluated on Serum omentin-1 levels (p=< 0.001). Obesity was associated with significantly lower serum omentin-1 levels compared to non-obese individuals (median 140.31 vs 210.97 ng/mL; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: